208
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Barriers to Medication Adherence Among Patients with Non-Communicable Disease in North Wollo Zone Public Hospitals: Socio-Ecologic Perspective, 2023

ORCID Icon, , , ORCID Icon, , ORCID Icon, , ORCID Icon, , , ORCID Icon, & ORCID Icon show all
Pages 733-744 | Received 14 Dec 2023, Accepted 11 Mar 2024, Published online: 21 Mar 2024

References

  • De Geest S, Sabaté E. Adherence to long-term therapies: evidence for action. Europ J Cardiovas Nurs. 2003;2(4):323.
  • Ho PM, Bryson CL, Rumsfeld J. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028–3035. doi:10.1161/CIRCULATIONAHA.108.768986
  • Mongkhon P, Ashcroft DM, Scholfield CN, Kongkaew C. Hospital admissions associated with medication non-adherence: a systematic review of prospective observational studies. BMJ Qual Safet. 2018;27(11):902–914. doi:10.1136/bmjqs-2017-007453
  • Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x
  • Banatvala N, Bovet P. Noncommunicable Diseases: A Compendium. Taylor & Francis; 2023.
  • Han E, Suh D-C, Lee S-M, Jang S, Pharmacy A. The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study. Res Soc Administ Pharm. 2014;10(6):e87–e98. doi:10.1016/j.sapharm.2014.02.001
  • Kanyongo W, Ezugwu AEJIi MU. Feature selection and importance of predictors of non-communicable diseases medication adherence from machine learning research perspectives. Informat Med Unlock. 2023;2023:101232.
  • World Health Organization. Noncommunicable Diseases Progress Monitor 2022. World Health Organization; 2022.
  • Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.0030442
  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069.
  • Li Z, Shi J, Li N, et al. Temporal trends in the burden of non-communicable diseases in countries with the highest malaria burden, 1990–2019: evaluating the double burden of non-communicable and communicable diseases in epidemiological transition. JAMA. 2022;18(1):1–9.
  • Hegelund MH, Fjordside L, Faurholt‐Jepsen D, Christensen DL, Bygbjerg IC. Opportunistic non‐communicable diseases in times of COVID‐19. APMIS. 2023;131(1):13–18. doi:10.1111/apm.13274
  • Blaakman SW, Cohen A, Fagnano M, Halterman JSJJo A. Asthma medication adherence among urban teens: a qualitative analysis of barriers, facilitators and experiences with school-based care. J Asthma. 2014;51(5):522–529. doi:10.3109/02770903.2014.885041
  • Maghsoudi Z, Sadeghi A, Oshvandi K, Ebadi A, Tapak LJJo GN. Barriers to treatment adherence among older adults with type 2 diabetes: a qualitative study. J Gerontol Nurs. 2023;49(1):42–49. doi:10.3928/00989134-20221206-04
  • Nies YH, Ali AM, Abdullah N, Islahudin F, Shah N. A qualitative study among breast cancer patients on chemotherapy: experiences and side-effects. Pat Pref Adhere. 2018;12:1955–1964. doi:10.2147/PPA.S168638
  • Wan BK, Cheung WH, Ball PA, Jackson DM, Maynard GJJIJo PP. Beliefs about medicines among Hong Kong hospital outpatients. Internat J Pharm Pract. 2017;25(6):447–453. doi:10.1111/ijpp.12353
  • King DE, Mainous AG, Carnemolla M, Everett C. Adherence to healthy lifestyle habits in US adults, 1988-2006. Am J Med. 2009;122(6):528–534. doi:10.1016/j.amjmed.2008.11.013
  • Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diab Med. 2015;32(6):725–737. doi:10.1111/dme.12651
  • Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–943. doi:10.1136/thx.2009.113662
  • Abaka MK, Chinemerem EE, Rejimon PM, et al. Medication adherence: gaining insights on patient-reported facilitators and barriers; 2023.
  • Ahmed EH, Abdel-Aziz HR, Ahmed S. Medication adherence and its influencing factors in community-dwelling older adults with chronic illnesses in a rural area. Nursing Practice Today. 2023. doi:10.18502/npt.v10i3.13434
  • Barr EL, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation. 2007;116(2):151–157.
  • Kasahun AE, Sendekie AK, Mekonnen GA, et al. Impact of personal, cultural and religious beliefs on medication adherence among patients with chronic diseases at university hospital in northwest Ethiopia. Pat Prefer Adhere. 2022;16:1787–1803. doi:10.2147/PPA.S370178
  • Wilson DH, Rein LJ, Fountain M, Brookhart A, Atchley D, Hohmeier K. A pilot study exploring the impact of a primary medication non-adherence intervention among four chronic disease states in one regional division of a large community pharmacy chain. Pharmacy. 2023;11(1):11. doi:10.3390/pharmacy11010011
  • Atinga RA, Yarney L, Gavu N. Factors influencing long-term medication non-adherence among diabetes and hypertensive patients in Ghana: a qualitative investigation. PLoS One. 2018;13(3):e0193995. doi:10.1371/journal.pone.0193995
  • Lulebo AM, Mutombo PB, Mapatano MA, et al. Predictors of non-adherence to antihypertensive medication in Kinshasa, democratic republic of congo: a cross-sectional study. BMC Res Note. 2015;8(1):1–8.
  • Lemstra M, Nwankwo C, Bird Y, Moraros J. Primary nonadherence to chronic disease medications: a meta-analysis. Pat Prefere Adhere. 2018;12:721–731. doi:10.2147/PPA.S161151
  • Wu J-R, Lennie TA, Dekker RL, Biddle MJ, Moser DK. Medication adherence, depressive symptoms, and cardiac event–free survival in patients with heart failure. J Card Fail. 2013;19(5):317–324. doi:10.1016/j.cardfail.2013.03.010
  • Malaeb D, Sacre H, Mansour S, et al. Assessment of medication adherence among Lebanese adult patients with non-communicable diseases during COVID-19 lockdown: a cross-sectional study. Front Pub Health. 2023;11:1145016. doi:10.3389/fpubh.2023.1145016
  • Amer MAK, Mohiuddin SI, Shafeeque Shaikh D. Enhancing medication adherence in chronic patients. Saudi J Med Pharm Sci. 2023;9(6):346–351.
  • Bhattarai B, Walpola R, Mey A, Anoopkumar-Dukie S, Khan S. Barriers and strategies for improving medication adherence among people living with COPD: a systematic review. Respirat Care. 2020;65(11):1738–1750. doi:10.4187/respcare.07355
  • Delamater AM. Improving patient adherence. Clinical Diabetes. 2006;24(2):71–77.
  • García-Pérez L-E, Álvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabet Thera. 2013;4(2):175–194. doi:10.1007/s13300-013-0034-y
  • Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. Coch Datab System Rev. 2014;2014(11). doi:10.1002/14651858.CD000011.pub4
  • Peng Y, Wang H, Fang Q, et al. Effectiveness of mobile applications on medication adherence in adults with chronic diseases: a systematic review and meta-analysis. J Manag Care. 2020;26(4):550–561. doi:10.18553/jmcp.2020.26.4.550
  • Tolley A, Hassan R, Sanghera R, et al. Interventions to promote medication adherence for chronic diseases in India: a systematic review. Front Public Health. 2023;11:1194919.
  • Amankwaa I, Boateng D, Quansah DY, Akuoko CP, Evans C. Effectiveness of short message services and voice call interventions for antiretroviral therapy adherence and other outcomes: a systematic review and meta-analysis. PLoS One. 2018;13(9):e0204091.
  • Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982. doi:10.1136/bmjopen-2017-016982
  • Haynes R, Ackloo E, Sahota N, McDonald H, Yao X. Interventions for enhancing medication adherenceCochrane. Database Syst Rev. 2008;2008:1.
  • Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff. 2011;30(1):91–99. doi:10.1377/hlthaff.2009.1087
  • Carpenter DM, DeVellis RF, Fisher EB, et al. The effect of conflicting medication information and physician support on medication adherence for chronically ill patients. Pat Educ Counsel. 2010;81(2):169–176. doi:10.1016/j.pec.2009.11.006
  • Hawes EM, Sanders KA. Medication management and treatment adherence. In: Chronic Illness Care: Principles and Practice. Springer; 2023:181–193.
  • Herrera PA, Moncada L, Defey D. Understanding non-adherence from the inside: hypertensive patients’ motivations for adhering and not adhering. Qualit Health Res. 2017;27(7):1023–1034. doi:10.1177/1049732316652529
  • Zairina E, Nugraheni G, Sulistyarini A, et al. Factors related to barriers and medication adherence in patients with type 2 diabetes mellitus: a cross-sectional study. J Diab Metab Dis. 2022;21(1):219–228. doi:10.1007/s40200-021-00961-6
  • McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Quart. 1988;15(4):351–377. doi:10.1177/109019818801500401
  • Denzin NK, Lincoln YS. Introduction: the discipline and practice of qualitative research. Hand Qualit Res. 2000;2(1):1–20.
  • Tolley EE, Ulin PR, Mack N, Robinson ET, Succop SM. Qualitative Methods in Public Health: A Field Guide for Applied Research. John Wiley & Sons; 2016.
  • Berek PA, Siswanto BB, Irawati D, Jatmiko W. Individual characteristics, adherence, and barriers to medication adherence of hypertensive patients at the Indonesia-timor leste border. Nurs Med J Nurs. 2022;12:3.
  • O’Donnell M, Hankey GJ, Rangarajan S, et al. Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level. Heart. 2021;107(4):282–289.
  • Baiardini I, Rogliani P, Santus P, et al. Disease awareness in patients with COPD: measurement and extent. Internat J Chron Obstruc Pulm Dis. 2018;14:1–11. doi:10.2147/COPD.S179784
  • Berhane Y, Worku A. Adherence to antihypertensive treatment and associated factors in central Ethiopia. Internat J Hypert. 2020;2020:1.
  • Ni Z, Dardas L, Wu B, Shaw R. Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review. Heart Asia. 2019;11:2.
  • Kvarnström K, Airaksinen M, Liira H. Barriers and facilitators to medication adherence: a qualitative study with general practitioners. BMJ Open. 2018;8(1):e015332. doi:10.1136/bmjopen-2016-015332
  • Alosaimi K, Alwafi H, Alhindi Y, et al. Medication adherence among patients with chronic diseases in Saudi Arabia. Internat J Environ Res Public Health. 2022;19(16):10053. doi:10.3390/ijerph191610053
  • Yap AF, Thirumoorthy T, Kwan Y. Systematic review of the barriers affecting medication adherence in older adults. Geriat Gerontol Internat. 2016;16(10):1093–1101. doi:10.1111/ggi.12616
  • Gala P, Kamano JH, Sanchez MV, et al. Cross-sectional analysis of factors associated with medication adherence in western Kenya. BMJ Open. 2023;13(9):e072358. doi:10.1136/bmjopen-2023-072358
  • Macquart de Terline D, Kane A, Kramoh KE, et al. Factors associated with poor adherence to medication among hypertensive patients in twelve low and middle income Sub-Saharan countries. PLoS One. 2019;14(7):e0219266. doi:10.1371/journal.pone.0219266
  • Morgan SG, Lee A. Cost-related non-adherence to prescribed medicines among older adults: a cross-sectional analysis of a survey in 11 developed countries. BMJ Open. 2017;7(1):e014287. doi:10.1136/bmjopen-2016-014287
  • Mebrahtu G, M Moleki M, Okoth Achila O, et al. Antihypertensive medication adherence and associated factors: a cross-sectional analysis of patients attending a National Referral Hospital in Asmara, Eritrea. Patient Pref Adhere. 2021;2021:2619–2632.
  • De Avila JL, Meltzer DO, Zhang J. Prevalence and persistence of cost-related medication nonadherence among Medicare beneficiaries at high risk of hospitalization. JAMA Network Open. 2021;4(3):e210498–e. doi:10.1001/jamanetworkopen.2021.0498
  • Hong J, Kim G. Difference in health-related quality of life between medical aid beneficiaries and health insurance beneficiaries using the community health survey. J Korea Cont Assoc. 2016;16(5):477–487.
  • Yoon S, Kwan YH, Yap WL, et al. Factors influencing medication adherence in multi-ethnic Asian patients with chronic diseases in Singapore: a qualitative study. Front Pharmacol. 2023;14:1124297. doi:10.3389/fphar.2023.1124297
  • Nielsen JØ, Shrestha A, Neupane D, Kallestrup P. Non-adherence to anti-hypertensive medication in low-and middle-income countries: a systematic review and meta-analysis of 92443 subjects. J Hum Hypert. 2017;31(1):14–21. doi:10.1038/jhh.2016.31
  • Xu J, Zhao M, Vrosgou A, et al. Barriers to medication adherence in a rural-urban dual economy: a multi-stakeholder qualitative study. BMC Health Serv Res. 2021;21:1–9.
  • Olagbemide OJ, Omosanya OE, Ayodapo AO, Agboola SM, Adeagbo AO, Olukokun TA. Family support and medication adherence among adult type 2 diabetes: any meeting point? Anna Afr Med. 2021;20(4):282. doi:10.4103/aam.aam_62_20
  • Alhabib MY, Alhazmi TS, Alsaad SM, AlQahtani AS, Alnafisah A. Medication adherence among geriatric patients with chronic diseases in Riyadh, Saudi Arabia. Patient Prefere Adhere. 2022;16:2021–2030. doi:10.2147/PPA.S363082
  • Shruthi R, Jyothi R, Pundarikaksha H, Nagesh G, Tushar T. A study of medication compliance in geriatric patients with chronic illnesses at a tertiary care hospital. J Clin Diagn Res. 2016;10(12):FC40. doi:10.7860/JCDR/2016/21908.9088
  • Al-Noumani H, Alharrasi M, Lazarus ER, Panchatcharam SM. Factors predicting medication adherence among Omani patients with chronic diseases through a multicenter cross-sectional study. Scient Rep. 2023;13(1):7067. doi:10.1038/s41598-023-34393-4
  • Krishnamoorthy Y, Rajaa S, Rehman T, Thulasingam M. Patient and provider’s perspective on barriers and facilitators for medication adherence among adult patients with cardiovascular diseases and diabetes mellitus in India: a qualitative evidence synthesis. BMJ Open. 2022;12(3):e055226. doi:10.1136/bmjopen-2021-055226
  • Henry Osokpo O, James R, Riegel B. Maintaining cultural identity: a systematic mixed studies review of cultural influences on the self‐care of African immigrants living with non‐communicable disease. J Advan Nurs. 2021;77(9):3600–3617. doi:10.1111/jan.14804
  • Numsang P, Oumtanee A, Kurat S, Sananok R, Kraichan S, Sarapoke P. “Failure to control blood sugar” experiences of persons with type 2 diabetes mellitus. Internat J Nurs Sci. 2023;10:527–532. doi:10.1016/j.ijnss.2023.09.004
  • Sari Y, Yusuf S, Kusumawardani LH, Sumeru A, Sutrisna EJH. The cultural beliefs and practices of diabetes self-management in Javanese diabetic patients: an ethnographic study. Heliyon. 2022;8(2). doi:10.1016/j.heliyon.2022.e08873
  • Pardhan S, Upadhyaya T, Smith L, et al. Individual patient-centered target-driven intervention to improve clinical outcomes of diabetes, health literacy, and self-care practices in Nepal: a randomized controlled trial. Front Endocrinol. 2023;14:1076253. doi:10.3389/fendo.2023.1076253
  • Konstantinou P, Kassianos AP, Georgiou G, et al. Barriers, facilitators, and interventions for medication adherence across chronic conditions with the highest non-adherence rates: a scoping review with recommendations for intervention development. Translat Behav Med. 2020;10(6):1390–1398. doi:10.1093/tbm/ibaa118
  • Wilkinson R, Garden E, Nanyonga RC, et al. Causes of medication non-adherence and the acceptability of support strategies for people with hypertension in Uganda: a qualitative study. Internat J Nurs Stud. 2022;126:104143. doi:10.1016/j.ijnurstu.2021.104143
  • Kvarnström K, Westerholm A, Airaksinen M, Liira HJP. Factors contributing to medication adherence in patients with a chronic condition: a scoping review of qualitative research. Pharmaceutics. 2021;13(7):1100. doi:10.3390/pharmaceutics13071100
  • Vialle-Valentin CE, Serumaga B, Wagner AK, Ross-Degnan D. Evidence on access to medicines for chronic diseases from household surveys in five low-and middle-income countries. Health Pol Plann. 2015;30(8):1044–1052. doi:10.1093/heapol/czu107
  • Tusubira AK, Akiteng AR, Nakirya BD, et al. Accessing medicines for non-communicable diseases: patients and health care workers’ experiences at public and private health facilities in Uganda. PLoS One. 2020;15(7):e0235696. doi:10.1371/journal.pone.0235696